Remove Inpatient Remove Insurance Coverage and Processing Remove Presentation
article thumbnail

ProxsysRx’s Meds To Beds Program Makes Immediate Impact Upon Launch At TMH

Proxsys Rx

In 2022 alone, TMH’s 710+ physicians, and its medical staff, saw 31,190 inpatient admissions. Even with her insurance coverage, the co-pay was beyond her means. If it had been a large chain pharmacy, she would have essentially been presented with the option of paying a bill she couldn’t afford — or doing without.

article thumbnail

ProxsysRx’s Meds To Beds Program Makes Immediate Impact Upon Launch At TMH

Proxsys Rx

In 2022 alone, TMH’s 710+ physicians, and its medical staff, saw 31,190 inpatient admissions. Even with her insurance coverage, the co-pay was beyond her means. If it had been a large chain pharmacy, she would have essentially been presented with the option of paying a bill she couldn’t afford — or doing without.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NHC Comments on CMS 2026 Notice of Benefit and Payment Parameters

Putting Patients First Blog

General Support for CMS Proposals The NHC commends CMS for its ongoing commitment to advancing health equity, improving access to care, ensuring program integrity, and maintaining affordability through Marketplace coverage. Copay Assistance and Drug Coverage in Large Group Plans Accumulator Adjustment Programs and Cost Sharing.

article thumbnail

How early planning leads to successful market access and drug launch in Europe

Pharmaceutical Technology

Launching a new drug can be a risky business, with regulatory approval no guarantee that private, commercial, and government-funded insurers will reimburse it. Meanwhile, in Germany, the AMNOG process is conducted twelve months after the drug is launched, thus giving freedom to the company to set the drug’s price during this period.